Dow Jones Top Company Headlines at 1 AM ET: First Brands' New Management Accuses Founder Patrick James of Fraud | The ... The bankrupt auto supplier filed a complaint against its founder alleging that ...

Novo Nordisk’s weight-loss drug Wegovy could soon have a new sales outlet in the U.S. T elehealth company Hims & Hers Health ...

Revenue rose 49% year-over-year to nearly $600 million, while net income reached $15.8 million and adjusted EBITDA climbed 53 ...

Get key Q3 2025 earnings insights for Hims & Hers Health (HIMS): revenue growth, new partnerships, and global expansion plans.

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

Hims and Hers Health beat Wall Street estimates for third-quarter revenue on Monday, as the telehealth company added ...

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

On behalf of our sponsors at Tonum Health, we're leaning about the millions of Americans using weight loss medications like Ozempic and Wegovy. There's now a growing conversation around what happens ...

In June, Novo ended a partnership with Hims & Hers that provided access to Wegovy through the pharma's Novocare Pharmacy because Hims & Hers was trying to skirt legal restrictions on compounding ...

The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments ...

Molecule is claimed to be made from "natural ingredients" such as dandelion root and fennel seed, but investigations tell a different story ...

New survey data shows 37 percent of US adults are currently classed as obese, down from a record high of 39.9 percent in 2022 ...